Health Products

Contrave Tablet (Extended Release) (2018-08-06)

· Published by Health Canada · Official notice

Details

Alert type: Drug Recall
Category: Drugs
Issue: Product Safety
Audience: General Public, Healthcare Professionals, Hospitals
Department: Health Canada
Hazard classification: Type II
Get told about the next health product recall.

We email or text you when Canada issues a recall that matches what you watch: a brand, a product, an allergen. Most never make the news.

Get health product recall alerts

CA$3.99/mo · cancel anytime

Products

Lot or serial numberCompaniesBrand nameDosage formDIN, NPN, DIN-HIMStrength
ZNPZ, ZNSC
Recalling Firm
Valeant Canada LP
2150 St-Elzear Boulevard West,
Laval
H7L 4A8
Quebec
CANADA
Marketing Authorization Holder
Valeant Canada LP
2150 St-Elzear Boulevard West,
Laval
H7L 4A8
Quebec
CANADA
Contrave Tablet (Extended Release)Tablet (Extended Release)DIN 02472945Bupropion hydrochloride 90mg

Introduction

Recalled Products

Contrave Tablet (Extended Release)

Reason

The bottles of affected lots could be perforated.

Depth of distribution

Retailers
Get told about the next health product recall.
Get health product recall alerts

CA$3.99/mo · cancel anytime